A nonprofit health advocacy group wants Bayer correct its marketing techniques — this one involving its Men’s One A Day multivitamin.
The Washington, D.C.-based Center for Science in the Public Interest (CSPI) is suing the German drug giant for allegedly claiming falsely that selenium in the men’s multivitamin might reduce the risk of prostate cancer.
The lawsuit, filed in San Francisco Superior Court, comes on the heels of several multimillion-dollar settlements that Bayer has paid out to resolve claims about misleading advertising. This year, Bayer agreed to run a $20 million corrective advertising campaign about its birth control pill Yaz.
In 2007, it paid a $3.2 million fine over weight loss claims involving its One A Day vitamin as part of a consent decree reached with the Federal Trade Commission and the U.S. Department of Justice and another $8 million to resolve allegations, raised by state attorneys general, that it hid safety issues surrounding its cholesterol-lowering drug Baycol.
Dallas Fort Worth Injury Lawyer Blog


